Longevity Life Sciences

Longevity Life Sciences is an Australian-based biotech company pioneering the next generation of regulated longevity therapeutics. As the parent company of Elevate, a premium consumer brand, and CellVive, our proprietary NMN ingredient, we are redefining how the world approaches ageing, from treatment to prevention. Built at the intersection of clinical rigour, translational science, and commercial scalability, our mission is to extend human healthspan through evidence-based interventions that support cellular resilience, metabolic health and healthy ageing. Our growing pipeline includes next-generation NAD+ precursors, mitochondrial enhancers, sirtuin activators, and gut-longevity modulators. Each is being developed with leading academic institutions to meet regulatory requirements and create defensible IP across both supplement and pharmaceutical categories. Longevity Life Sciences in uniquely placed to lead the global shift from unregulated longevity hype to science-backed trusted interventions that improve quality of life as we age.